These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8825627)

  • 1. The genetic mapping and gene structure of mouse paraoxonase/arylesterase.
    Sorenson RC; Primo-Parmo SL; Camper SA; La Du BN
    Genomics; 1995 Dec; 30(3):431-8. PubMed ID: 8825627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy to prevent organophosphate intoxication.
    Cowan J; Sinton CM; Varley AW; Wians FH; Haley RW; Munford RS
    Toxicol Appl Pharmacol; 2001 May; 173(1):1-6. PubMed ID: 11350209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural organization of the human PON1 gene.
    Clendenning JB; Humbert R; Green ED; Wood C; Traver D; Furlong CE
    Genomics; 1996 Aug; 35(3):586-9. PubMed ID: 8812495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.
    Wills AM; Landers JE; Zhang H; Richter RJ; Caraganis AJ; Cudkowicz ME; Furlong CE; Brown RH
    Neurology; 2008 Mar; 70(12):929-34. PubMed ID: 18347314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor.
    Deakin S; Leviev I; Brulhart-Meynet MC; James RW
    Biochem J; 2003 Jun; 372(Pt 2):643-9. PubMed ID: 12639220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family.
    Primo-Parmo SL; Sorenson RC; Teiber J; La Du BN
    Genomics; 1996 May; 33(3):498-507. PubMed ID: 8661009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities.
    Bryk B; BenMoyal-Segal L; Podoly E; Livnah O; Eisenkraft A; Luria S; Cohen A; Yehezkelli Y; Hourvitz A; Soreq H
    J Neurochem; 2005 Mar; 92(5):1216-27. PubMed ID: 15715671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
    Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
    Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the mouse dihydrolipoamide dehydrogenase (Dld) gene: genomic structure, promoter sequence, and chromosomal localization.
    Johnson M; Yang HS; Johanning GL; Patel MS
    Genomics; 1997 May; 41(3):320-6. PubMed ID: 9169128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum paraoxonase and arylesterase activities in hemodialysis patients.
    Itahara T; Suehiro T; Ikeda Y; Inoue M; Nakamura T; Kumon Y; Kawada M; Hashimoto K
    J Atheroscler Thromb; 2000; 7(3):152-8. PubMed ID: 11480456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism.
    Furlong CE; Li WF; Costa LG; Richter RJ; Shih DM; Lusis AJ
    Neurotoxicology; 1998; 19(4-5):645-50. PubMed ID: 9745924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis.
    Shih DM; Gu L; Xia YR; Navab M; Li WF; Hama S; Castellani LW; Furlong CE; Costa LG; Fogelman AM; Lusis AJ
    Nature; 1998 Jul; 394(6690):284-7. PubMed ID: 9685159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity.
    Sorenson RC; Bisgaier CL; Aviram M; Hsu C; Billecke S; La Du BN
    Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2214-25. PubMed ID: 10479665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arylesterase and paraoxonase activity of paraoxonase (PON1) affected by ischemia in the plasma of patients with arterial occlusion of the lower limbs.
    Kasprzak M; Iskra M; Majewski W; Wielkoszyński T
    Clin Biochem; 2009 Jan; 42(1-2):50-6. PubMed ID: 18976644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and chromosomal localization of mouse G protein subunit gamma 4 gene.
    Kalyanaraman S; Copeland NG; Gilbert DG; Jenkins NA; Gautam N
    Genomics; 1998 Apr; 49(1):147-51. PubMed ID: 9570961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
    Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T
    Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic organization, expression, and chromosomal mapping of the mouse adrenomedullin gene.
    Okazaki T; Ogawa Y; Tamura N; Mori K; Isse N; Aoki T; Rochelle JM; Taketo MM; Seldin MF; Nakao K
    Genomics; 1996 Nov; 37(3):395-9. PubMed ID: 8938454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic organization, 5'-flanking region, and chromosomal localization of the human RGS3 gene.
    Chatterjee TK; Eapen A; Kanis AB; Fisher RA
    Genomics; 1997 Oct; 45(2):429-33. PubMed ID: 9344672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative status and serum PON1 activity in beta-thalassemia minor.
    Selek S; Aslan M; Horoz M; Gur M; Erel O
    Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic structure and chromosomal mapping of MyD88.
    Hardiman G; Jenkins NA; Copeland NG; Gilbert DJ; Garcia DK; Naylor SL; Kastelein RA; Bazan JF
    Genomics; 1997 Oct; 45(2):332-9. PubMed ID: 9344657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.